Chairman Dr. Ahmed Jamaloodeen - 06 Oct 2026 Form 4 Insider Report for ProText Mobility, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Oct 2026, 08:51:46 UTC
Prior SEC filing
28 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dr. Ahmed Jamaloodeen, Chairman and President

Key filing fact

Chairman Dr. Ahmed Jamaloodeen filed Form 4 for ProText Mobility, Inc. on 08 Oct 2026.

Key facts

  • This page summarizes Chairman Dr. Ahmed Jamaloodeen's Form 4 filing for ProText Mobility, Inc..
  • 9 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 08 Oct 2026, 08:51.

Change

  • Previous filing in this sequence was filed on 28 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002131747 Primary reporting owner

Jamaloodeen Ahmed

Relationship
Chairman and President, 10%+ Owner
Address
C/O PROTEXT MOBILITY, INC., ONE WEST LAS OLAS BLVD., STE 500, FORT LAUDERDALE
Signature
/s/ Dr. Ahmed Jamaloodeen, Chairman and President
Signature date
06 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Series D Preferred Stock

Award

Transaction value
Shares
+66,667
Change %
Price
$0.001000*
Shares after
66,667
Date
03 Jun 2022
Ownership
Direct
No ticker transaction

Series A Preferred Stock

Award

Transaction value
Shares
+33,333
Change %
Price
$0.001000*
Shares after
33,333
Date
03 Jun 2022
Ownership
Direct
No ticker transaction

Common Stock

Purchase

Transaction value
Shares
+89,866,874
Change %
+80%
Price
Shares after
202,366,874
Date
31 Dec 2024
Ownership
Direct
Footnotes
F1, F2
No ticker transaction

Common Stock

Purchase

Transaction value
Shares
+7,170,075
Change %
+3.5%
Price
Shares after
209,536,949
Date
30 Sep 2025
Ownership
Direct
Footnotes
F1, F2
No ticker transaction

Common Stock

Purchase

Transaction value
Shares
+45,212,287
Change %
+22%
Price
Shares after
254,749,236
Date
07 Apr 2026
Ownership
Direct
Footnotes
F1, F2
No ticker transaction

Common Stock

Purchase

Transaction value
Shares
+520,905,768
Change %
+204%
Price
Shares after
775,655,004
Date
20 May 2026
Ownership
Direct
Footnotes
F1, F2
No ticker transaction

Common Stock

Purchase

Transaction value
Shares
+55,646,456
Change %
+7.2%
Price
Shares after
831,301,460
Date
06 Oct 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Series D Convertible Preferred Stock

Award

Transaction value
Shares
+66,667
Change %
Price
$0.001000*
Shares after
66,667
Date
03 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Exercise price
$0.002000
Footnotes
F3, F4
No ticker transaction Derivative

Series A Convertible Preferred Stock

Award

Transaction value
Shares
+33,333
Change %
Price
$0.001000*
Shares after
33,333
Date
03 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Exercise price
$0.002000
Footnotes
F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Common Stock rows reflect the open-ended discretionary stock purchase program previously disclosed for Dr. Ahmed Jamaloodeen. Actual purchases were made over time at prevailing market prices on OTC Markets and/or through private purchases from other shareholders. The 05/20/2026 row is not intended to identify a single purchase made only on 05/20/2026; it reports, in aggregate, the cumulative additional shares acquired after the 04/07/2026 ownership report and through 05/20/2026. The aggregate amount reported for that period is 520,905,768 shares, calculated as current total beneficial ownership of 775,655,004 shares less the 254,749,236 shares shown as owned following the 04/07/2026 row.

Footnote F2

The Shares Owned Following Transaction column states the total beneficial ownership as of the ending date shown. The 10/06/2026 row is not intended to identify a single purchase made only on 10/06/2026; it reports, in aggregate, the cumulative additional shares acquired after the 05/20/2026 ownership report and through 10/06/2026. The aggregate amount reported for that period is 55,646,456 shares, calculated as current total beneficial ownership of 831,301,460 shares less the 775,655,004 shares shown as owned following the 05/20/2026 row. The Shares Owned Following Transaction column states the total beneficial ownership as of the ending date shown.

Footnote F3

Series D Convertible Preferred Stock and Series A Convertible Preferred Stock have no conversion expiration date.

Footnote F4

Series D Convertible Preferred Stock converts to 75% of post-conversion common stock.

Footnote F5

Series A Convertible Preferred Stock converts to 10% of post-conversion common stock.

SEC remarks

Voluntary Filing. This Form 4 is being filed voluntarily in the interest of transparency, good corporate governance, and as part of the Company's ongoing efforts to align its disclosure practices with SEC reporting standards. ProText Mobility, Inc. (TXTM) currently trades on OTC Markets under the Alternative Reporting Standard. This filing reports additional Common Stock acquired over time under the Reporting Person's open-ended discretionary stock purchase program after May 20, 2026 and through October 6, 2026. The Table I 10/06/2026 row is presented as an aggregate period update and updates the Reporting Person's common-stock beneficial ownership to 831,301,460 shares as of October 6, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .